CTNNB1 and cancer: For instance, while most CRCs harbor APC mutations, a subset of CRCs and other cancers lacking APC mutations have CTNNB1 gene mutations resulting in production of oncogenic β-catenin proteins that are resistant to regulation by the destruction complex and that activate β-catenin/TCF transcription [6, 13].